Skip to main content

Advertisement

SpringerLink
Log in

Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio Between Positive and Examined Lymph Nodes

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The purpose of this study was to evaluate the impact of the negative lymph node (NLN) count on the prognostic prediction of the ratio between positive and examined lymph nodes (RML) in gastric cancer after curative resection.

Methods

The positive and negative node counts were determined for 456 patients who underwent curative resection for gastric cancer. Overall survival was examined according to clinicopathologic variables. The correlation between the NLN count and the aforementioned best variable for prediction the disease-specific overall survival was examined.

Results

The NLN count cutoffs were designed as 0–9, 10–14, and ≥15, with the 5-year survival rate 4.1, 30.7, and 74.8%, respectively. RML of 98 patients who had an NLN count of nine or fewer was ≥40%. The median survival of these patients was 12 months. Of 88 patients who had 10 to 14 NLN count, 7 had 74-month median survival with 0.1–10% RML, 52 had 47-month median survival with 10.1–40% RML, and 29 had 22-month median survival with >40% RML. Of 270 patients who had ≥15 NLN count, 157 had 114-month median survival without positive nodes, 62 had 98-month median survival with 0.1–10% RML, 45 had 40-month median survival with 10.1–40% RML, and 6 had 14-month median survival with >40% RML.

Conclusions

The NLN count is a key factor for improvement of survival prediction of RML in gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Manfe AZ, Segalina P, Maffei Faccioli A. Prognostic factors in gastric cancer. Our experience and review of the literature. Minerva Chir 2000;55:299–305.

    CAS  PubMed  Google Scholar 

  2. Yokota T, Kunii Y, Teshima S, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg 2000;85:286–90.

    CAS  PubMed  Google Scholar 

  3. Ding YB, Chen GY, Xia JG, et al. Association of VCAM-1 Overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2003;9:1409–14.

    CAS  PubMed  Google Scholar 

  4. Abe N, Watanabe T, Suzuki K, et al. Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg 2002;183:168–72.

    Article  PubMed  Google Scholar 

  5. Yamaguchi T, Sano T, Katai H, Sasako M, Maruyama K. Node positive mucosal gastric cancer: a follow-up study. Jpn J Clin Oncol 2001;31:153–6.

    Article  CAS  PubMed  Google Scholar 

  6. Chen CY, Wu CW, Lo SS, et al. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology 2002;49:874–7.

    PubMed  Google Scholar 

  7. Pan W, Ishii H, Ebihara Y, Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol 2003;82:104–10.

    Article  PubMed  Google Scholar 

  8. Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 2006;107:2143–51.

    Article  PubMed  Google Scholar 

  9. Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The appropriate cutoffs of positive lymph nodes to evaluate the prognosis of gastric cancer patients. J Surg Oncol 2008;98:343–8.

    Article  PubMed  Google Scholar 

  10. Wu CW, Hsieh MC, Lo SS, et al. Comparison of the UICC/AJCC 1992 and 1997 pN categories for gastric cancer patients after surgery. Hepatogastroenterology 2001;48:279–84.

    CAS  PubMed  Google Scholar 

  11. Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of the new international union against cancer TNM staging for gastric carcinoma. Cancer 2000;88:1796–800.

    Article  CAS  PubMed  Google Scholar 

  12. Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 1990;170:488–94.

    CAS  PubMed  Google Scholar 

  13. Shiu MH, Perrotti M, Brennan MF. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989;36:7–12.

    CAS  PubMed  Google Scholar 

  14. Jaehne J, Meyer HJ, Maschek H, et al. Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg 1992;127:290–4.

    CAS  PubMed  Google Scholar 

  15. Adachi Y, Kamakura T, Mori M, et al. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994;81:414–6.

    Article  CAS  PubMed  Google Scholar 

  16. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: Wiley; 1997.

    Google Scholar 

  17. Hayashi H, Ochiai T, Suzuki T, et al. Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery 2000;127:129–35.

    Article  CAS  PubMed  Google Scholar 

  18. Omejc M, Juvan R, Jelenc F, Repse S. Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg 2001;86:14–9.

    CAS  PubMed  Google Scholar 

  19. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9:27–34.

    Article  PubMed  Google Scholar 

  20. Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002;26:323–9.

    Article  PubMed  Google Scholar 

  21. Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003;10:1077–85.

    Article  PubMed  Google Scholar 

  22. Marchet A, Mocellin S, Ambrosi A, et al. Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543–52.

    Article  PubMed  Google Scholar 

  23. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1998;1:10–24.

  24. Smith DD, Schwarz RR, Schwartz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005;23:7114–24.

    Article  PubMed  Google Scholar 

  25. Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection of gastric cancer: a population-based study. Eur J Cancer 2000;36:390–6.

    Article  CAS  PubMed  Google Scholar 

  26. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005;241:27–39.

    PubMed  Google Scholar 

  27. Okajima K. Prognostic factors of gastric cancer patients-a study by univariate and multivariate analysis. Jpn J Gastroenterol Surg 1997;30:700–11.

    Google Scholar 

  28. Aiko T, Sasako M. The new Japanese Classification of Gastric Carcinoma: points to be revised. Gastric Cancer 1998;1:25–30.

    Article  PubMed  Google Scholar 

  29. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775–84.

    Article  PubMed  Google Scholar 

  30. Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 2005;12:981–7.

    Article  PubMed  Google Scholar 

  31. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1,038 patients. Ann Surg 2000;232:362–71.

    Article  CAS  PubMed  Google Scholar 

  32. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.

    Google Scholar 

  33. Deng JY, Liang H, Sun D, et al. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer. Eur J Surg Oncol 2009;35:814–9.

    CAS  PubMed  Google Scholar 

  34. Bouvier AM, Haas O, Piard F, et al. How many nodes must be examined to accurately stage gastric adenocarcinomas? Results from a population based study. Cancer 2002;94:2862–6.

    Article  PubMed  Google Scholar 

  35. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T; Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278–86.

    Article  PubMed  Google Scholar 

  36. Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg 1996;183:616–24.

    CAS  PubMed  Google Scholar 

  37. Saito H, Fukumoto Y, Osaki T, et al. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 2008;97:132–5.

    Article  PubMed  Google Scholar 

  38. Xu DZ, Geng QR, Long ZJ, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 2009;16:319–26.

    Article  PubMed  Google Scholar 

  39. Marchet A, Mocellin S, Ambrosi A, et al; Italian Research Group for Gastric Cancer Study (GIRCG). The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 2008;34:159–65.

    CAS  PubMed  Google Scholar 

  40. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in respectable gastric cancer of advanced stage. Ann Surg Oncol 2007;14:317–28.

    Article  PubMed  Google Scholar 

  41. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006;24:3570–5.

    Article  PubMed  Google Scholar 

  42. Kim JJ, Song KY, Hur H, et al. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol 2009;35:409–14.

    CAS  PubMed  Google Scholar 

  43. Saito H, Osaki T, Murakami D, et al. Recurrence in early gastric cancer—presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology 2007;54:620–4.

    PubMed  Google Scholar 

  44. Endo K, Kohnoe S, Okamura T, et al. Evaluation of endoscopic mucosal resection and nodal micrometastasis in pN0 submucosal gastric cancer. Oncol Rep 2005;13:1059–63.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastric Cancer Surgery Division, Tianjin Medical University Cancer Hospital and City Key Laboratory of Tianjin Cancer Center, Tianjin, China

    Jingyu Deng MD, Han Liang MD, Xuewei Ding MD & Xiangyu Liu MD

  2. Hepatobiliary Cancer Surgery Division, Tianjin Medical University Cancer Hospital and City Key Laboratory of Tianjin Cancer Center, Tianjin, China

    Dianchang Wang MD

  3. Institute of Lung Cancer, Tianjin Medical University General Hospital, Tianjin, China

    Dan Sun MS

  4. Pathological Division, Tianjin Medical University Cancer Hospital and City Key Laboratory of Tianjin Cancer Center, Tianjin, China

    Yi Pan MD

Authors
  1. Jingyu Deng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Han Liang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dianchang Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dan Sun MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xuewei Ding MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi Pan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiangyu Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Han Liang MD.

Additional information

X. Ding, MD is the Joint First Author, email: dingxuew@hotmail.com.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deng, J., Liang, H., Wang, D. et al. Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio Between Positive and Examined Lymph Nodes. Ann Surg Oncol 17, 1043–1051 (2010). https://doi.org/10.1245/s10434-009-0863-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0863-0

Keywords

Search

Navigation